Skip to main content

Esma Yolcu, PhD

Yolcu Headshot

Professor of Child Health, School of Medicine
Professor of Molecular Microbiology and Immunology, School of Medicine

NextGen Focus Area: Cancer

Dr. Yolcu has a significant interest in using hematopoietic stem cells for the treatment of bone marrow failure syndrome and hematological malignancies as well as a means of immunomodulation to prevent/treat type 1 diabetes and allograft rejection. Imperative to these efforts is the development of a novel proprietary platform technology (ProtExTM) that allows; i) the generation of novel immune ligands with robust immune stimulatory or suppressive functions; and ii) the temporary display of these ligands, either individually or in combination, on biological and non-biological surfaces for localized immunomodulation. 

Precision Health Impact:

  • Learning how to treat autoimmune diseases, including type 1 diabetes 
  • Investigating use of hematopoietic stem cells for immunomodulation 

Email: esma.yolcu@health.missouri.edu
Department website: https://www.medicine.missouri.edu/faculty/esma-yolcu-phd